Journal of Transcatheter Valve Therapies (JTVT) is a peer-reviewed, open access journal publishing articles on Transcatheter Valve Therapies. Published continuously online, the journal is fully indexed in J-STAGE. JTVT welcomes submissions from around the world.

About the journal

Journal of Transcatheter Valve Therapies is an official journal of Japan Transcatheter Valve Therapies (Society) .

Read more >

Instructions to Authors

Journal of Transcatheter Valve Therapies supplies comprehensive and clear Instructions to Authors, which offer guidance on article types and format, journal policies, and how to submit manuscripts.

Read more >

The journal welcomes submissions from around the world. Please consult the Instructions to Authors and the Author Checklist.

Latest articlesView more articles >

Original ArticleMay 21, 2024

Prognostic Impact of Peak Tricuspid Regurgitation Velocity in Patients Undergoing Transcatheter Aortic Valve Implantation

Kayo Sugiyama, Masato Tochii, Masanobu Fujimoto, Wataru Suzuki, Hirotaka Watanuki, Daisuke Koiwa, Tetsuya Amano, Katsuhiko Matsuyama

Objective: No appropriate guidelines concerning perioperative management of transcatheter aortic valve implantation (TAVI) exist for patients with aortic valve stenosis (AS) and concomitant pulmonary hypertension. Peak tricuspid regurgitation velocity (PTRV) has been estimated to be a non-invasive representation of pulmonary artery pressure.

Read full Article >

Original ArticleMay 1, 2024

Mid-Term Clinical Outcomes of Redo-Transcatheter Aortic Valve Replacement in Japanese Patients

Koichi Maeda, Kazuo Shimamura, Kizuku Yamashita, Ai Kawamura, Isamu Mizote, Daisuke Nakamura, Yasuharu Takeda, Yasushi Sakata, Shigeru Miyagawa

Objective: Only a few reports have detailed the early- to mid-term outcomes of transcatheter aortic valve replacement (TAVR), especially in patients with small body size. This study aimed to evaluate the early- and mid-term outcomes of redo-TAVR in Japanese patients. Methods: This was a retrospective, non-randomized, single-center study. In all 16 consecutive cases (15 patients) who underwent redo-TAVR (excluding redo-TAVR because of intraoperative bailout) were enrolled in this study.

Read full Article >

ReviewApril 20, 2024

Contemporary Surgical Treatment for Functional Mitral Regurgitation

Soh Hosoba, Riku Kato, Koji Morita, Masato Mutsuga

The treatment of functional mitral regurgitation (FMR) has evolved dramatically in recent years and remains dynamic. Generally, the treatment of FMR involves a combination of medication optimization and surgical or transcatheter interventions. The use of transcatheter edge-to-edge repair has been increasing for FMR. This less invasive approach allows for transcatheter mitral valve repair, avoiding open heart surgery. On the other hand, surgical mitral valve repair techniques, such as annuloplasty, still play a crucial role in managing FMR. Simultaneous surgical ablation for atrial fibrillation or left atrial appendage closure can be performed.

Read full Article >